The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: Results of a systematic review with meta-analysis

Archives of Disease in Childhood

Volumn 95, Issue 5, 2010, Pages 365-370

  Castro Rodriguez, Jose A ^a   Rodrigo, Gustavo J ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; MONTELUKAST; SALBUTAMOL; TRIAMCINOLONE;

ADOLESCENT; ADVERSE DRUG REACTION; ARTICLE; ASTHMA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LUNG FUNCTION; META ANALYSIS; MONOTHERAPY; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ACETATES; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; PEAK EXPIRATORY FLOW RATE; QUINOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77953745061     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.169177     Document Type: Article

References (39)

1. Martinez FD. Trends in asthma prevalence, admission rates, and asthma deaths. Respir Care 2008;53:561-5.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention. Revised 2007. http://www.ginasthma.com (accessed 22 December 2007).
3. National Heart, Lung, and Blood Institute. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 2007. http://www.nhlbi.nih.gov (accessed Dec 2007).
4. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008;63:1-121.
5. Ducharme F, di Salvio F. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database Syst Rev 2004;1:CD002314. (Pubitemid 32971214)
6. Ducharme F. Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2004;1:CD003133.
7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12. (Pubitemid 26120810)
8. Cohen J. Statistics analysis for the behavioral sciences. Orlando, FL: Academic Press, 1977.
9. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in metaanalyses. BMJ 2003;327:557-60.
10. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
12. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326:219.
13. Rosenberg MS. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Evolution 2005;59:464-8.
14. Máspero JF, Dueñas-Meza E, Volovitz B, et al. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin 2001;17:96-104. (Pubitemid 32964000)
15. Williams B, Noonan G, Reiss TF, et al. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clin Exp Allergy 2001;31:845-54. (Pubitemid 34204256)
16. Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy 2002;32:264-9. (Pubitemid 34429606)
17. Stelmach I, Majak P, Jerzynska J, et al. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: a randomized pragmatic study. Pediatr Allergy Immunol 2004;15:359-64. (Pubitemid 39093494)
18. Garcia ML, Wahn U, Gilles L, et al. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 2005;116:360-9. (Pubitemid 44161461)
19. Ostrom NK, Decotiis BA, Lincourt WR, et al. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr 2005;147:213-20.
20. Stelmach I, Bobrowska-Korzeniowska M, Majak P, et al. The effect of montelukast and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. Pulm Pharmacol Ther 2005;18:374-80. (Pubitemid 40804536)
21. Szefler SJ, Phillips BR, Martinez FD, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005;115:233-42.
22. Becker AB, Kuznetsova O, Vermeulen J, et al. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. Ann Allergy Asthma Immunol 2006;96:800-7. (Pubitemid 43911795)
23. Zeiger RS, Szefler SJ, Phillips BR, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 2006;117:45-52.
24. Kumar V, Ramesh P, Lodha R, et al. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial. J Trop Pediatr 2007;53:325-30. (Pubitemid 350120326)
25. Sorkness CA, Lemanske RF Jr, Mauger DT, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64-72.
26. Szefler SJ, Baker JW, Uryniak T, et al. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. J Allergy Clin Immunol 2007;120:1043-50. (Pubitemid 350029914)
27. Simons FE, Villa JR, Lee BW, et al. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. J Pediatr 2001;138:694-8.
28. Jat GC, Mathew JL, Singh M. Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial. Ann Allergy Asthma Immunol 2006;97:397-401. (Pubitemid 44476578)
29. Miraglia del Giudice M, Piacentini GL, Capasso M, et al. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide. Respir Med 2007;101:1809-13.
30. Karaman O, Sünneli L, Uzuner N, et al. Evaluation of montelukast in 8 to 14 year old children with mild persistent asthma and compared with inhaled corticosteroids. Madrid, Spain: Allergol Immunopathol 2004;32:21-7.
31. Stelmach I, Grzelewski T, Bobrowska-Korzeniowska M, et al. A randomized, double-blind trial of the effect of anti-asthma treatment on lung function in children with asthma. Pulm Pharmacol Ther 2007;20:691-700.
32. Jartti T. Inhaled corticosteroids or montelukast as the preferred primary longterm treatment for pediatric asthma? Eur J Pediatr 2008;167:731-6.
33. Martinez FD. Managing childhood asthma: challenge of preventing exacerbations. Pediatrics 2009;123:S146-50.
34. Hoskins G, McCowan C, Neville RG, et al. Risk factors and costs associated with an asthma attack. Thorax 2000;55:19-24.
35. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83.
36. Castro-Rodriguez JA, Rodrigo GJ. Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis. Pediatrics 2009;123:e519-25.
37. Rodrigo GJ, Moral VP, Marcos LG, et al. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review. Pulm Pharmacol Ther 2009;22:9-19.
38. Carter ER, Ananthakrishnan M. Adherence to montelukast versus inhaled corticosteroids in children with asthma. Pediatr Pulmonol 2003;36:301-4.
39. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999;354:1896-900.